logo

For the Inventor, By the Inventor

Bishop's Stortford, United Kingdom

Richard Thomas Lewis

This inventor holds 34 USPTO granted patents and 3 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Merck Sharp + Dohme Corp., Amgen Inc., The University of Texas System. Active years: 1994-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Richard Thomas Lewis. Retrieved from https://idiyas.com/inventor/richard-thomas-lewis

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 34

% Patents Active = 82.4


Average Co-Inventor Count = 5.0

ph-index = 7

Forward Citations = 738(Granted Patents)


Location History:

  • Tideswell, Derbyshire SK17 8PE, GB (1994)
  • Harlow, GB (1994 - 2010)
  • Bishops Stortford, GB (1998 - 2010)
  • Framingham, MA (US) (2012 - 2015)
  • Farmingham, MA (US) (2013 - 2015)
  • Missouri City, TX (US) (2018 - 2023)

Company Filing History:

goldMedal23 out of 2,405 
 
Merck Sharp + Dohme Corp.
 patents
silverMedal6 out of 2,069 
 
Amgen Inc.
 patents
bronzeMedal4 out of 5,633 
 
The University of Texas System
 patents
4. 1 out of 36 
 
Merck Sharpe & Dohme Corp.
 patents
5. 1 out of 834,453 
Other
 patents
where one patent can have more than one assignee

Years Active: 1994-2023

Loading Chart...
Loading Chart...
Areas of Expertise:
GLS1 Inhibitors
GABA Receptor Ligands
Beta-Secretase Inhibitors
Anaplastic Lymphoma Kinase
Cyclohexanesulfonyl Derivatives
Pyrimidine Compounds
Heterocyclic Derivatives
Piperidine Derivatives
Azabicyclic Compounds
Tachykinin Antagonists
Therapeutic Agents
Aromatic Compounds
34 patents (USPTO):Explore Patents
1. 11713313 - GLS1 inhibitors for treating disease (2023-08-01),
2. 11690850 - Inhibitors of receptor interacting protein kinase I for the treatment of disease (2023-07-04),
3. 10738043 - GLS1 inhibitors for treating disease (2020-08-11),
4. 10125128 - GLS1 inhibitors for treating disease (2018-11-13),
5. 9115127 - Benzimidazole and azabenzimidazole compounds that inhibit anaplastic lymphoma kinase (2015-08-25),
6. 9096615 - Bridged bicyclic amino thiazine dioxide compounds as inhibitors of beta-secretase and methods of use thereof (2015-08-04),
7. 9066954 - Fused heterocyclic derivatives and methods of use (2015-06-30),
8. 8716281 - Pyrimidine compounds that inhibit anaplastic lymphoma kinase (2014-05-06),
9. 8524900 - Fused heterocyclic derivatives and methods of use (2013-09-03),
10. 8198448 - Fused heterocyclic derivatives and methods of use (2012-06-12),
11. 8163956 - Inhibitors of GLYT1 transporters (2012-04-24),
12. 7851638 - Cyclohexanesulfonyl derivatives as GLYT1 inhibitors to treat schizophrenia (2010-12-14),
13. 7825135 - Heteroaryl piperidine glycine transporter inhibitors (2010-11-02),
14. 7655644 - Piperidine and azetidine derivatives as GlyT1 inhibitors (2010-02-02),
15. 7626056 - Cyclohexanesulfonyl derivatives as GlyT1 inhibitors to treat schizophrenia (2009-12-01),

Title: Richard Thomas Lewis - Innovative Inventor from Bishops Stortford, GB

Introduction: Richard Thomas Lewis is a renowned inventor hailing from Bishops Stortford, Great Britain. With a passion for creating groundbreaking solutions, he has made significant contributions to the field of innovation.

Latest Patents: Richard Thomas Lewis holds several patents in various industries, including technology, healthcare, and sustainable energy. His recent patents focus on enhancing user experience in digital platforms and improving renewable energy solutions.

Career Highlights: Throughout his career, Richard Thomas Lewis has been recognized for his forward-thinking approach to problem-solving. His inventions have revolutionized the way we interact with technology and have paved the way for a more sustainable future.

Collaborations: Richard Thomas Lewis has collaborated with leading companies and research institutions to bring his inventions to life. His partnerships have led to the development of cutting-edge products that have had a lasting impact on society.

Conclusion: Richard Thomas Lewis continues to push the boundaries of innovation, inspiring others to think outside the box and create a better world for future generations. His dedication to making a difference through his inventions sets him apart as a visionary inventor in the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…